Antihistamine after a heart attack
Part of Heart & circulation clinical trials.
This trial tests whether taking an antihistamine medicine called fexofenadine hydrochloride can help people recover better after a heart attack. It is a randomized study, so some participants will receive the medicine and others will receive a placebo (a pill with no active ingredients).
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You had a type of heart attack called STEMI, confirmed by chest pain, blood tests, and ECG changes.
- You had emergency heart procedure (coronary angiography) to open a blocked artery.
- An ultrasound of the heart showed your heart pump function is reduced (LVEF at or below 50%).
- You have not had a previous heart attack, heart bypass surgery, or long-term use of fexofenadine or similar allergy medicines.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether dexmedetomidine can protect the heart in people who are having a specific type of heart attack (anterior STEMI) when treated within 6 hours of symptom start. You may be considered if your diagnosis and vital signs fit the study safety rules, and if you can take part in follow-up.
This trial tests whether a drug called butylphthalide, given with a stent procedure, can reduce heart damage and improve recovery after a heart attack. You may join if you are having a heart attack and can get treated quickly.
This study tests whether giving a medication called adenosine before emergency heart catheterization (a tube procedure to open blocked arteries) helps patients having a heart attack. Adenosine may protect heart tissue and improve outcomes.
This trial tests if the allergy medicine fexofenadine can improve recovery after a heart attack. You may qualify if you had a specific type of heart attack (STEMI) within the last week.
This trial adds a Chinese medicine (Shexiang Baoxin Pill) to standard care for people having a heart attack, to see if it improves recovery when taken alongside the usual artery-opening procedure. It may help speed up heart recovery and reduce further damage.
This trial tests whether giving a combination of antioxidant vitamins (supplements) during emergency treatment for a first heart attack can reduce heart muscle damage and improve recovery. You might be eligible if you are having an emergency angioplasty for a recent heart attack.
Hear when a new ST-segment Elevation Myocardial Infarction (STEMI) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.